Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes

BACKGROUND: The majority of patients diagnosed with advanced epithelial ovarian carcinoma (EOC) relapse with resistant disease, and there are no biomarkers that possess clinical utility to identify or monitor these patients. This study aimed to identify secreted proteins (‘secretome') collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, P-N, Wang, G, Hood, B L, Conrads, K A, Hamilton, C A, Maxwell, G L, Darcy, K M, Conrads, T P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887292/
https://www.ncbi.nlm.nih.gov/pubmed/24178762
http://dx.doi.org/10.1038/bjc.2013.687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887292/
https://www.ncbi.nlm.nih.gov/pubmed/24178762
http://dx.doi.org/10.1038/bjc.2013.687

Ejemplares similares